Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTUMI-4: Mirtazapine and Folic Acid as Add-on Therapy for Schizophrenia
2009-014469-19Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Mirtazapine add-on with Folic acid add-on (2 arms). Primary endpoint: Change in PANSS total score. Started Jul 2010; status: completed.
02
Drugs
mirtazapinefolic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-014469-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014469-19.